M Warmuth-Metz
Overview
Explore the profile of M Warmuth-Metz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benesch M, Perwein T, Apfaltrer G, Langer T, Neumann A, Brecht I, et al.
AJNR Am J Neuroradiol
. 2022 Sep;
43(10):1523-1529.
PMID: 36137663
Background And Purpose: Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC) is a new, molecularly defined glioneuronal CNS tumor type. The objective of the present study was to...
2.
Stock A, Mynarek M, Pietsch T, Pfister S, Clifford S, Goschzik T, et al.
AJNR Am J Neuroradiol
. 2019 Oct;
40(11):1811-1817.
PMID: 31649159
Background And Purpose: In addition to the 4 histopathologically defined entities of medulloblastoma, 4 distinct genetically defined subgroups have been included in the World Health Organization classification of 2016. The...
3.
Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, JANSSEN G, Graf N, et al.
J Neurooncol
. 2019 Mar;
143(1):107-113.
PMID: 30830679
Background: Diffuse intrinsic pontine glioma (DIPG) is a devastating cancer of childhood and adolescence. Methods: The study included patients between 3 and 20 years with clinically and radiologically confirmed DIPG....
4.
Rodriguez D, Chambers T, Warmuth-Metz M, Aliaga E, Warren D, Calmon R, et al.
AJNR Am J Neuroradiol
. 2019 Mar;
40(3):568-575.
PMID: 30819765
Background And Purpose: HERBY was a Phase II multicenter trial setup to establish the efficacy and safety of adding bevacizumab to radiation therapy and temozolomide in pediatric patients with newly...
5.
Keil V, Warmuth-Metz M, Reh C, Enkirch S, Reinert C, Beier D, et al.
AJNR Am J Neuroradiol
. 2017 Aug;
38(10):1892-1898.
PMID: 28798218
Background And Purpose: The occurrence of medulloblastomas in adults is rare; nevertheless, these tumors can be subdivided into genetic and histologic entities each having distinct prognoses. This study aimed to...
6.
Nunes R, Hsu C, da Rocha A, Do Amaral L, Godoy L, Watkins T, et al.
AJNR Am J Neuroradiol
. 2017 Jul;
38(10):1899-1904.
PMID: 28705817
Multinodular and vacuolating neuronal tumor of the cerebrum is a recently reported benign, mixed glial neuronal lesion that is included in the 2016 updated World Health Organization classification of brain...
7.
Jaspan T, Morgan P, Warmuth-Metz M, Aliaga E, Warren D, Calmon R, et al.
AJNR Am J Neuroradiol
. 2016 Apr;
37(9):1581-7.
PMID: 27127006
Determination of tumor response to treatment in neuro-oncology is challenging, particularly when antiangiogenic agents are considered. Nontumoral factors (eg, blood-brain barrier disruption, edema, and necrosis) can alter contrast enhancement independent...
8.
Warmuth-Metz M, Bison B
Clin Neuroradiol
. 2015 May;
25 Suppl 2:123-6.
PMID: 25994758
No abstract available.
9.
Daubenbuchel A, Hoffmann A, Gebhardt U, Warmuth-Metz M, Sterkenburg A, Muller H
Eur J Endocrinol
. 2015 Feb;
172(5):561-9.
PMID: 25650403
Objective: Pediatric patients with sellar masses such as craniopharyngioma (CP) or cyst of Rathke's pouch (CRP) frequently suffer disease- and treatment-related sequelae. We analyzed the impact and prognostic relevance of...
10.
Bode U, Zimmermann M, Moser O, Rutkowski S, Warmuth-Metz M, Pietsch T, et al.
J Neurooncol
. 2014 Sep;
120(3):635-42.
PMID: 25179451
Early studies with high-dose chemotherapy for treatment of relapsed cerebral PNET had shown modest efficacy but considerable toxicity. The HIT97 national trial tested a nonrandomized but stratified relapse protocol using...